TYP ASX Chart
Snapshot
Tryptamine Therapeutics Limited (TYP, formerly Exopharm Limited) is a leader in advanced manufacturing technologies for exosome-based medicines. Exosomes can be loaded with a variety of active pharmaceutical ingredients (APIs) and can be targeted to selected cell types and tissue types, improving the safety profile of the APIs and providing better treatments. Exosomes can be used to deliver small molecule drugs, mRNA, DNA and other types of APIs.
Share Price Activity (ASX)
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
Performance
1 Week | |
1 Month | |
2024 YTD | |
1 Year | |
vs Sector (1yr) | - |
vs ASX 200 (1yr) | -7.98% |
Top Market Index News
Announcements
Corporate Overview
Corporate Details
Head Office | |
Website | - |
Registry | Automic Group |
Auditor | William Buck Audit (VIC) Pty Ltd |
Date Listed | 18 Dec 2018 |
Upcoming Calendar (Forecasted)
Date | Event |
---|---|
27/08/2024 | Report (Prelim) |
27/08/2024 | Report (Annual) |
25/02/2025 | Report (Interim) |
Former Company Names
- Exopharm Limited (EX1), 03/05/2024
Sponsored Financial Content
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
TYP directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of TYP directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
Altnia Holdings Pty Ltd | 02/08/2023 | 28,258,627 | 6.43 |
William Garner | 01/05/2024 | 198,926,720 | 17.47 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
Date | Name | Bought | Previous % | New % |
---|---|---|---|---|
01-05-24 | William Garner | 198,926,720 | -- | 17.47 |
Shareholders Selling
12 month transaction history compiled from ASX announcements.
Date | Name | Sold | Previous % | New % |
---|---|---|---|---|
01-05-24 | Ian E Dixon | 28,258,627 | 6.43 | -- |
Historical Data
Share Price History
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Historical Data
Year | Closing Price | Last Trade |
---|---|---|
No Financial Year End data available |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.